SARS-CoV-2 Neutralizing Antibodies discovered using upfront blocking assay

At Antibody Engineering & Therapeutics 2020 virtual conference, SCT presented a poster titled "SARS-CoV-2 Neutralizing Antibodies Discovered Fast: A Novel Blocking assay to Speed to the Finish." This poster highlights our work on SARS-CoV-2, the virus that causes COVID-19. Our work is still in progress.

To view the poster, click here.

To view Allison Schulkins 5 minute presentation of the poster, check out the video below.